NCT05015686View on ClinicalTrials.gov

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

2,400

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

February 9, 2022

Study Completion Date

September 20, 2026

Conditions
Varicella
Interventions
BIOLOGICAL

Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

live varicella-zoster virus in 0·5 mL of sucrose, sodium glutamate,sodium chloride,potassium chloride,sodium dihydrogen phosphate, potassium dihydrogen phosphate and injection water per injection

BIOLOGICAL

Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd

live varicella-zoster virus in trehalose,human serum albumin,sodium glutamate,sucrose,glucose,carbamide,arginine and injection water per injection

BIOLOGICAL

Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

live varicella-zoster virus in 0·5 mL of sucrose, sodium glutamate,sodium chloride,potassium chloride,sodium dihydrogen phosphate, potassium dihydrogen phosphate and injection water per injection

BIOLOGICAL

Placebo

Sodium chloride and distilled water

Trial Locations (1)

476300

Yucheng Center for Disease Control and Prevention, Shangqiu

All Listed Sponsors
lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY